Mutlu Keskin

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

aMMP-8 and MMP-9: Potential Biomarkers for periodontitis Progression in Patients Receiving Radiotherapy for Head and Neck Carcinoma.

aMMP-8 and MMP-9: Potential Biomarkers for periodontitis Progression in Patients Receiving Radiotherapy for Head and Neck Carcinoma.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: June 23, 2025

Point-of-Care Biomarker Monitoring of Treatment Efficacy: Changes in Mouthrinse Active Matrix Metalloproteinase-8 (aMMP-8) Concentrations Following Periodontal Anti-Infective Treatment.

Point-of-Care Biomarker Monitoring of Treatment Efficacy: Changes in Mouthrinse Active Matrix Metalloproteinase-8 (aMMP-8) Concentrations Following Periodontal Anti-Infective Treatment.

Journal: International journal of dentistry

Published: February 28, 2025

Periodontal Disease - A Late Complication of Head and Neck Cancer Radiotherapy.

Periodontal Disease - A Late Complication of Head and Neck Cancer Radiotherapy.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: May 17, 2024

Induction of Collagenolytic MMP-8 and -9 Tissue Destruction Cascade in Mouth by Head and Neck Cancer Radiotherapy: A Cohort Study.

Induction of Collagenolytic MMP-8 and -9 Tissue Destruction Cascade in Mouth by Head and Neck Cancer Radiotherapy: A Cohort Study.

Journal: Biomedicines

Published: November 06, 2023

Author Response: Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.

Author Response: Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: August 14, 2023

Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.

Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: April 24, 2023

Human β-Defensins in Diagnosis of Head and Neck Cancers.

Human β-Defensins in Diagnosis of Head and Neck Cancers.

Journal: Cells

Published: January 31, 2023

A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.

A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.

Journal: Diagnostics (Basel, Switzerland)

Published: January 04, 2023

Oral Cavity Calprotectin and Lactoferrin Levels in Relation to Radiotherapy.

Oral Cavity Calprotectin and Lactoferrin Levels in Relation to Radiotherapy.

Journal: Current issues in molecular biology

Published: August 29, 2022

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.

Journal: Frontiers in oral health

Published: March 15, 2022

Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.

Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.

Journal: Expert review of proteomics

Published: January 07, 2021

Two Cheers for Crohn's Disease and Periodontitis: Beta-Defensin-2 as an Actionable Target to Intervene on Two Clinically Distinct Diseases.

Two Cheers for Crohn's Disease and Periodontitis: Beta-Defensin-2 as an Actionable Target to Intervene on Two Clinically Distinct Diseases.

Journal: Omics : a journal of integrative biology

Published: July 15, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026